Final results of feasibility study of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil (DCF) for clinical stage II/III esophageal squamous cell carcinoma

被引：0
|
作者：
Hara, H.
Daiko, H.
Kato, K.
Igaki, H.
Kadowaki, S.
Tanaka, Y.
Hamamoto, Y.
Matsushita, H.
Nagase, M.
Hosoya, Y.
Tahara, M.
机构：
[1] Saitama Canc Ctr, Saitama, Japan
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr, Tokyo, Japan
[4] Tochigi Canc Ctr, Utsunomiya, Tochigi, Japan
[5] Jichi Med Univ Hosp, Shimotsuke, Tochigi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.4060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4060
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Feasibility study of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil (DCF) for clinical stage II/III esophageal squamous cell carcinoma
    Kato, K.
    Hara, H.
    Daiko, H.
    Igaki, H.
    Hamamoto, Y.
    Nagase, M.
    Kadowaki, S.
    Tahara, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [2] Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma
    Hara, Hiroki
    Tahara, Makoto
    Daiko, Hiroyuki
    Kato, Ken
    Igaki, Hiroyasu
    Kadowaki, Shigenori
    Tanaka, Yoichi
    Hamamoto, Yasuo
    Matsushita, Hisayuki
    Nagase, Michitaka
    Hosoya, Yoshinori
    [J]. CANCER SCIENCE, 2013, 104 (11) : 1455 - 1460
  • [3] FEASIBILITY STUDY OF NEOADJUVANT CHEMORADIOTHERAPY WITH CISPLATIN PLUS 5-FLUOROURACIL FOR CLINICAL STAGE II/III ESOPHAGEAL SQUAMOUS CELL CARCINOMA
    Hara, H.
    Hashimoto, J.
    Kato, K.
    Ito, Y.
    Igaki, H.
    Kojima, T.
    Daiko, H.
    Akimoto, T.
    Hamamoto, Y.
    Matsushita, H.
    Katano, S.
    Tanaka, Y.
    Saito, Y.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 91 - 91
  • [4] Effects of Neoadjuvant 5-Fluorouracil and Cisplatin Therapy in Patients with Clinical Stage II/III Esophageal Squamous Cell Carcinoma
    Konishi, Hirotaka
    Fujiwara, Hitoshi
    Shiozaki, Atsushi
    Shoda, Katsutoshi
    Kosuga, Toshiyuki
    Kubota, Takeshi
    Okamoto, Kazuma
    Otsuji, Eigo
    [J]. ANTICANCER RESEARCH, 2018, 38 (02) : 1017 - 1023
  • [5] Clinical Stage II or III Esophageal Squamous Cell Carcinoma and Neoadjuvant Chemotherapy: Further Considerations
    Mine, Shinji
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2198 - 2199
  • [6] Clinical Stage II or III Esophageal Squamous Cell Carcinoma and Neoadjuvant Chemotherapy: Further Considerations
    Shinji Mine
    [J]. Annals of Surgical Oncology, 2024, 31 : 2198 - 2199
  • [7] Clinical Stage II or III Esophageal Squamous Cell Carcinoma and Neoadjuvant Chemotherapy: Further Considerations
    Mine, Shinji
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2198 - 2199
  • [8] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma
    Sasaki, Ken
    Uchikado, Yasuto
    Omoto, Itaru
    Arigami, Takaaki
    Osako, Yusaku
    Noda, Masahiro
    Okumura, Hiroshi
    Maemura, Kosei
    Higashi, Ryutaro
    Yoshiura, Takashi
    Natsugoe, Shoji
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 581 - 587
  • [9] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma
    Ken Sasaki
    Yasuto Uchikado
    Itaru Omoto
    Takaaki Arigami
    Yusaku Osako
    Masahiro Noda
    Hiroshi Okumura
    Kosei Maemura
    Ryutaro Higashi
    Takashi Yoshiura
    Shoji Natsugoe
    [J]. Cancer Chemotherapy and Pharmacology, 2019, 83 : 581 - 587
  • [10] Feasibility study of neoadjuvant chemoradiotherapy with cisplatin plus 5-fluorouracil and elective nodal irradiation for stage II/III esophageal squamous cell carcinoma.
    Kojima, Takashi
    Hashimoto, Jun
    Kato, Ken
    Ito, Yoshinori
    Igaki, Hiroyasu
    Daiko, Hiroyuki
    Onozawa, Masakatsu
    Hamamoto, Yasuo
    Shimizu, Hideaki
    Katano, Susumu
    Hara, Hiroki
    Tanaka, Yoichi
    Saito, Yoshihiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345